Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.

David L Steffy

Richard E. Ragsdale

Community Health Systems, Inc.

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.

Avalon GloboCare Corp.

Health Management Associates is an independent, national research and consulting firm specializing in publicly funded healthcare and human services policy, programs, financing, and evaluation. Self-described as employing over 700 experts with extensive knowledge in healthcare.

Health Management Associates

VML Health is a full-service specialist health network that offers expertise in creating brands and experiences across the health ecosystem. It focuses on connecting organizations and communities to advance health outcomes.

VML Health

Community Health Systems is a healthcare provider developing and operating healthcare delivery systems in various markets. CHS operates multiple acute-care hospitals and other sites of care, offering a range of healthcare services.

Community Health Systems (CHS)

Community Health Systems is one of the nation’s leading healthcare providers. Developing and operating healthcare delivery systems in 40 distinct markets across 15 states, CHS is committed to helping people get well and live healthier. CHS affiliates operate 71 acute-care hospitals and more than 1,000 other sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.

Metric
Company Name	Community Health Systems, Inc.	Avalon GloboCare Corp.	Health Management Associates	VML Health
Symbol	CYH	AVCO
MSH ID	NET:CHS	COM:AVALON-GLOBOCARE	COM:HEALTHMANAGEMENT	COM:WUNDERMANTHOMPSON
Market	STOCKS	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Real Estate	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical - Care Facilities	Real Estate - Services	Health Consulting	Healthcare & Health Services
Country	US	US	US	US
Stage		Post-IPO
Employee Count	48K	5
Website	chs.net	avalon-globocare.com	healthmanagement.com	wundermanthompson.com/expertise
LinkedIn
Founders

Metric
Market Cap	464.15M	5.26M
Enterprise Value
Monthly Web Traffic	196.53K	88
Web Traffic Growth	0.20	-0.85
Valuation
Raised Capital		20M

Metric
Revenue	12.49B
Revenue (LTM)
Revenue (NTM)
Gross Profit	5.08B
EBITDA	1.39B
Operating Income	957M
Net Income	-133M
EPS	-1.02
Diluted EPS	-1.02
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.41
Operating Profit Margin	0.08
EBITDA Margin	0.11
Net Profit Margin	-0.01
Return on Equity	0.09
Return on Assets	-0.01
Return on Capital Employed	0.08

NET:CHS

Community Health Systems (CHS)

Last Close

3.75

22/11 21:00

Market Cap

464.15M

Beta: -

Volume Today

2.85M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	1.81
P/B Ratio	-0.33
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.07
EV Multiple	-7.85

Metric
Days Sales Outstanding	63.32
Days Payables Outstanding	41.31
Days Inventory Outstanding	16.16
Operating Cycle	82.01
Cash Conversion Cycle	45.49
Asset Turnover	0.87

Metric
Operating Cash Flow	210M
Free Cash Flow	-257M
Cash Flow to Debt	0.03
Operating Cash Flow/Sales	0.03
Free Cash Flow Yield	-0.79

Metric
Cash & Equivalents	38M
Accounts Receivable	-193M
Inventory	328M
Goodwill	3.96B
Debt to Capitalization	1.14
Debt to Assets	0.85
Current Ratio	1.51
Quick Ratio	1.33

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue
SG&A to Revenue	0.03